NCT05919888View on ClinicalTrials.gov

SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

November 14, 2023

Study Completion Date

November 14, 2023

Conditions

SurgerySurgical Site InfectionCutibacterium AcnesProsthetic-joint Infection

Interventions

DRUG

Povidone-Iodine

Applied to skin incision.

DEVICE

SURGX Wound Gel

Applied to skin incision.

Trial Locations (1)

63110

Saint Louis University, St Louis

Sponsors

Collaborators (1)

Next Science LLC

All Listed Sponsors

collaborator

Next Science LLC

UNKNOWN

lead

St. Louis University

OTHER

NCT05919888 - SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter